Apollo Hospitals Q4 Results: Cons PAT jumps 36% YoY to Rs 529 crore, revenue rises 18%; Rs 10 per share dividend declared

The hospital chain posted an 18% revenue growth to Rs 6,605 crore in Q4FY26 versus Rs 5,592 crore posted in the corresponding quarter of the previous financial year.

The company’s PAT grew 5.4% sequentially from Rs 502 crore in Q3FY26 while the topline increased 2% compared to Rs 6,477 crore in the October-December quarter of FY26.

The company’s board recommended a final dividend of Rs 10 per equity share for FY26 and has set the record date on August 14, 2026 for determining the shareholders who are entitled for the final dividend.

The company’s Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) in the quarter under review stood at Rs 1,011 crore, recording a 31% YoY growth.

Live Events

In its filing to the exchanges, the company reported strong growth in revenue and EBITDA across all three business verticals, as well as at the consolidated level, reflecting sustained operational momentum and resilient demand across healthcare services.
Healthcare service Q4FY26 performance
• Revenue at Rs 3,268 crore vs Rs 2,822 crore in Q4FY25; growth of 16% YoY
• EBITDA grew 14% at Rs 781 crore vs Rs 686 crore in Q4FY25; Margins at 23.9% in Q4FY26
• PAT stood at Rs 412 crore vs Rs 385 crore in Q4FY25, up 7% YoY

Apollo Health and Lifestyle Q4 performance
• Revenue at Rs 489 crore vs Rs 394 crore in Q4FY25; growth of 24% YoY
• EBITDA grew 58% at Rs 75 crore vs Rs 47 crore in Q4FY25; margins at 15.3% in Q4FY26
• PAT profit of Rs 10 crore vs loss of Rs 4 crore in Q4FY25

Apollo HealthCo Q4FY26 performance
• Revenue at Rs 2,848crore vs Rs 2,376 crore in Q4FY25; growth of 20% YoY
• EBITDA at Rs 156 crore vs Rs 36 crore in Q4FY25; margins at 5.5% in Q4FY26
• PAT stood at Rs 107 crore vs Rs 9 crore in Q4FY25

The company reported a strong consolidated performance for FY26, with revenue rising 16% YoY to Rs 25,229 crore compared with Rs 21,794 crore in FY25, driven by robust growth across its healthcare and digital platforms businesses.

EBITDA stood at Rs 3,769 crore against Rs 3,022 crore in the previous financial year, despite continued investments in Apollo 24/7, which incurred costs of Rs 467 crore during FY26, including a non-cash ESOP charge of Rs 118 crore.

Reported profit after tax (PAT) increased sharply to Rs 1,942 crore from Rs 1,446 crore in FY25, while diluted earnings per share (EPS) came in at Rs 134.95 for the year.

Meanwhile, Apollo 24/7 recorded a gross merchandise value (GMV) of Rs 2,037 crore, reflecting continued traction in the company’s digital healthcare ecosystem.

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)